Furthermore, m1A modification is associated with the responsiveness of tumor cells to immune checkpoint inhibitors (ICIs) (65, 95, 104, 111), such as regulating PD-L1 expression to influence tumor cell immune evasion. The gene discussed is CD274; the disease is neoplasm.